A meta-analysis of probiotic efficacy for gastrointestinal diseases

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Ritchie, Marina L ^a   Romanuk, Tamara N ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ADULT; ANTIBIOTIC ASSOCIATED DIARRHEA; ARTICLE; BIFIDOBACTERIUM LONGUM INFANTIS; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; GASTROINTESTINAL DISEASE; GROUPS BY AGE; HELICOBACTER INFECTION; HUMAN; ILEITIS; INFANT; INFECTIOUS DIARRHEA; IRRITABLE COLON; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; MAJOR CLINICAL STUDY; META ANALYSIS; NECROTIZING ENTEROCOLITIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SPECIES COMPOSITION; SPECIES DIFFERENCE; TRAVELLER DIARRHEA; TREATMENT DURATION;

AGE FACTORS; GASTROINTESTINAL DISEASES; HUMANS; PROBIOTICS; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84860003661     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034938     Document Type: Article

References (85)

1. McFarland LV, (2006) Meta-Analysis of Probiotics for the prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease. Am J Gastroenterol 101: 812-822.
2. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, et al. (2006) Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 6: 374-82.
3. Tong JL, Ran ZH, Shen J, Zhang CX, Xiao SD, et al. (2007) Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 25 (2): 155-68.
4. McFarland LV, Dublin S, (2008) Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 14 (17): 2650-2661.
5. Hoveyda N, Heneghan C, Mahtani KR, Rafael P, Roberts N, et al. (2009) A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterology 9: 15.
6. Isolauri E, (2001) Probiotics in human disease. Am J Clin Nutr 73 (suppl): 1142S-6S.
7. Sanderson IR, Walker WA, (1993) Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update). Gastroenterology 104: 622-39.
8. Carol M, Lambrechts A, Van Gossum A, Libin M, Goldman M, et al. (1998) Spontaneous secretion of interferon-γ and leukin 4 by human intraepithelial and lamina propria gut lymphocytes. Gut 42: 643-9.
9. Bengmark S, (1998) Ecological control of the gastrointestinal tract: the role of probiotic flora. Gut 42: 2-7.
10. Soutar A, Seaton A, Brown K, (1997) Bronchial reactivity and dietary antioxidants. Thorax 52: 166-70.
11. Sütas Y, Soppi E, Korhonen H, Syväoja EL, Saxelin M, et al. (1996) Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes. J Allergy Clin Immunol 98: 216-24.
12. Pessi T, Sütas Y, Saxelin M, Kallionen H, Isolauri E, (1999) Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria. Appl Environ Microbiol 65: 4725-8.
13. Johnston BC, Supina AL, Sunita Vohra, (2006) Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. CMAJ 175 (4): 377-83.
14. McFarland LV, (2000) Normal Flora: Diversity and functions. Micro Ecol Health Dis 12: 193-207.
15. Qamar A, Aboudola S, Warny M, Michetti P, Pothoulakis C, et al. (2001) Saccromyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect Immun 69: 2762-5.
16. Elmer GW, (2001) Probiotics: "Living Drugs." Am J Health Syst Pharm 58: 1101-9.
17. Deshpande G, Rao S, Patole S, (2007) Probiotics for prevention of necrotising Enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 369: 1614-1620.
18. Elahi B, Nikfar S, Derakhshani S, Vafaie M, Abdollahi M, et al. (2007) On the Benefit of Probiotics in the Management of Pouchitis in Patients Underwent Ileal Pouch Anal Anastomosis: A Meta-analysis of Controlled Clinical Trials. Dig Dis Sci 53: 1278-1284.
19. Hawrelak JA, Whitten DL, Myers SP, (2005) Is Lactobacillus rhamnosus GG Effective in Preventing the Onset of Antibiotic-Associated Diarrhoea: A Systematic Review. Digestion 72: 51-56.
20. Dendukuri N, Costa V, McGregor M, Brophy JM, et al. (2005) Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review. CMAJ 173 (2) doi:10.1503/cmaj.050350.
21. Santosa S, Farnworth E, Jones P, (2006) Probiotics and Their Potential Health Claims. Nutrition Reviews 64 (6): 265-274.
22. Saarela M, Lahteenmaki L, Crittenden R, Salminen S, Mattila-Sandholm T, (2002) Gut bacteria and health foods-the European perspective. Int J Food Microbiol 78: 99-117.
23. Sartor RB, (1995) Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 24: 475-507.
24. Rath HC, (2003) The role of endogenous bacterial flora: bystander or the necessary prerequisite? Eur J Gasrtroenterol Hepatol 15: 615-620.
25. Sakaguchi T, Kohler H, Gu X, McCormick BA, Reinecker HC, (2002) Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial cells. Cell Microbiol 4: 367-381.
26. Mimura T, Rizzello F, Helwig U, (2004) Once daily high dose probiotic therapy (VSL #3) for maintaining remission in recurrent or refactory Pouchitis. Gut 53: 108-114.
27. Hilton E, Kolakowski P, Singer C, Smith M, (1997) Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Travel Med 4: 41-43.
28. Halpern GM, Prindiville T, Blankenburg M, Hsia T, Gershwin ME, (1996) Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am J Gastroenterol 91: 1579-1585.
29. Isolauri E, Kaila M, Mykkänen H, Ling WH, Salminen S, (1994) Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci 39: 2595-600.
30. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH, (1994) Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344: 1046-9.
31. Isolauri E, Kaila M, Arvola T, Majamaa H, Rantala I, et al. (1993) Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats. Pediatr Res 33: 548-53.
32. Fric P, (2002) Probiotics in gastroenterology. Z Gastroenterol 40: 197-201.
33. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J, (2001) Protection from gastrointestinal disease with the use of probiotics. Am J Clin Nutr 73: 430S-436S.
34. Hart AL, Stagg AJ, Kamm MA, (2003) Use of Probiotics in the treatment of Inflammatory Bowel Disease. J Clin Gastroenterol 36 (2): 111-119.
35. Lin HC, (2004) Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 292: 852-858.
36. Sen S, Mullan MM, Parker TJ, Woolner JT, Tarry SA, et al. (2002) Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 47: 2615-2620.
37. Niedzielin K, Kordecki H, Birkenfeld B, (2001) A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 3: 1143-1147.
38. Gade J, Paraghurt TP, (1989) For the patients with irritable bowel syndrome. A controlled clinical investigation from general practice. Scand J Prim Health Care 7: 23-26.
39. Wenus C, Goll R, Loken EB, Biong AS, Halvorsen DS, et al. (2008) Prevention of antibiotic-associated diarrhea by a fermented probiotic milk drink. Eur J of Clin Nutr 62: 299-301.
40. Jaded AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, et al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 17: 1-12.
41. Bax L, (2010) MIX 2.0. Professional software for meta-analysis in Excel. Version (2.0.1.2). BiostatXL,http://www.meta-analysis-made-easy.com.
42. Sistrom CL, Garvan CW, (2004) Proportions, odds, and risk. Radiology 230 (1): 12-9.
43. Egger M, Davey Smith G, Schneider M, Minder C, et al. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
44. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
45. Egger M, Davey Smith G, (1995) Misleading meta-analysis. BMJ 311: 753-4.
46. Blumberg D, Beck DE, (2002) Surgery for ulcerative colitis. Gasroenterol Clin North Am 31: 219-235.
47. Kmiot WA, Youngs D, Tudor R, Thompson H, Keighley MRB, (1993) Mucosal morphology, cell proliferation and faecal bacteriology in acute Pouchitis. Br J Surg 80: 1445-1449.
48. Sandborn WJ, (1994) Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 107: 1856-60.
49. Keighley MR, (1996) Review article: the management of pouchitis. Aliment Pharmacol Ther 10: 449-57.
50. Nicholls RJ, Banerjee AK, (1998) Pouchitis: risk factors, etiology, and treatment. World J Surg 22: 347-51.
51. Ruseler-van Embden JG, Schouten WR, van Lieshout LM, (1994) Pouchitis: result of microbial imbalance? Gut 35: 658-64.
52. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ, (2002) Probiotics in the prevention of antibiotic associated diarrhea: meta-analysis. BMJ 324: 1361-6.
53. Cats A, Kuipers EJ, Bosschaerts AR, Pot PJG, Vandenbroucke-Grauls CMJE, (2003) Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment Pharmacol Ther 17: 429-435.
54. Olson JW, Maier RJ, (2002) Molecular hydrogen as an energy source for Helicobacter pylori. Science 298 (5599): 1788-90.
55. McFarland LV, (1998) Epidemiology, risk factors and treatments for antibiotic-associated diarrhea [review]. Dig Dis 16: 292-307.
56. Weizman Z, Asli G, Alsheikh A, (2005) Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115: 5-9.
57. Goodgame R, (2003) Emerging causes of Traveler's Diarrhea: Cryptosporidium, Cyclospora, Isospora, and Microsporidia. Current Infectious Disease Reports 5: 66-73.
58. Pozo- Olano JD, Warram JH, Gomez RG, Cavazos MG, (1978) Effect of a Lactobacillus preparation on traveller's diarrhea. Gastroenterology 74: 829-30.
59. Katelaris PH, Salam I, Farthing MJ, (1995) Lactobacilli to prevent traveler's diarrhea? N Engl J Med 333: 1046-49.
60. Wilson M, Bacteriology of Humans: An Ecological Perspective. Blackwell Publishing: Oxford, UK, 2008.
61. Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S, et al. (2007) Efficacy and Safety of Saccharomyces boulardii in the 14-day Triple Anti-Helicobacter pylori Therapy: A Prospective Randomized Placebo-Controlled Double Blind Study. Helicobacter 12: 309-316.
62. Ruszczynski M, Radzikowski A, Szajewska H, (2008) Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Aliment Pharmacol Ther 28: 154-161.
63. Gorbach SI, (1996) The discovery of Lactobacillus GG. Nutr Today 31 (6 suppl): 2-4S.
64. McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, et al. (1994) A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 271: 1913-8.
65. Orrhage K, Brismar B, Nord CE, (1994) Effects of supplements of Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin. Microb Ecol Health Dis 7: 17-25.
66. Van Neil C, (2005) Probiotics Not Just for Treatment Anymore. Pediatrics 115: 174-177.
67. Vanderhoof JA, (2000) Probiotics and intestinal inflammatory disorders in infants and children. J Pediatr Gastroenterol Nutr 30 (suppl 2): S34-S38.
68. Boulloche J, Mouterde O, Mallet E, (1994) Management of acute diarrhoea in infants and young children: controlled study of the anti-diarrhoeal efficacy of killed L. acidophilus (LB Strain) versus a placebo and a reference drug (loperamide). Ann Pediatr 41: 457-63.
69. Bodilis JY, (1983) Controlled clinical trial of Lacteol Fort compared with a placebo and reference drug in the treatment of acute diarrhea in the adult. Med Actuelle 10: 232-5.
70. Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, et al. (2000) A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 14: 1625-9.
71. Witsell DL, Garrett G, Yarbrough WG, Dorrestein SP, Drake AF, et al. (1995) Effect of Lactobacillus acidophilus on antibiotic-associated gastrointestinal morbidity: A prospective randomized trial. J Otolarynogol 24: 231-3.
72. Nobaek S, Johansson ML, Molin G, Ahrńe S, Jeppsson B, et al. (2000) Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 95: 1231-1238.
73. Simren M, Syrous A, Lindh A, Abrahamsson H, (2006) Effects of Lactobacillus plantarum 299v on symptoms and rectal sensitivity in patients with irritable bowel syndrome (IBS)- A randomized, double-blind controlled trial. Gastroenterology 130 (Suppl 2): A600.
74. Wult M, Hagslatt ML, Odenholt I, (2003) Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: A double-blind, placebo-controlled trial. Scand J Infect Dis 35: 365-7.
75. Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, et al. (2006) Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 101: 1581-1590.
76. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, et al. (2000) Oral Bacteriotheraphy as Maintenance Treatment in Patients with Chronic Pouchitis: A Double-Blind, Placebo-Controlled Trial. Gastroenterology 119: 305-309.
77. Gionchetti P, Amadini C, Rizzello F, Venturi A, Doggioli G, et al. (2003) Probiotics for the treatment of postoperative complications following intestinal surgery. Best Pract Res Clin Gastroenterol 17: 821-831.
78. Perin NM, Clandinin MT, Thomson ABR, (1997) Importance of milk and diet on the ontogeny and adaptation of the intestine. J pediatr Gastroenterol Nutr 24: 419-25.
79. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, et al. (1998) Functional food science and gastrointestinal physiology and function. Br J Nutr 80 (suppl): S147-71.
80. Simon SL, Gorbach SL, (1986) The human intestinal microflora. Dig Dis Sci 31 (suppl): 147S-62S.
81. Bezkorovainy A, (2001) Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr 73: 399S-405S.
82. Tannock GW, (1997) Probiotic properties of lactic-acid bacteria: plenty of scope for fundamental R & D. Trends Biotechnol 15: 270-4.
83. Benno Y, Mitsuoka T, (1992) Impact of Bifidobacterium longum on human fecal microflora. Microbiol Immunol 36: 683-94.
84. Ling WH, Korpela R, Mykkanen H, Salminen S, Hanninen, (1994) Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr 124: 18-23.
85. Cremonini F, Di Caro S, Nista EC, Bartolozzi F, Capelll G, et al. (2002) Meta-analysis: The effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 16: 1461-7.